FATE: Fate Therapeutics Inc
今日FATE汇率已更改13.33%。当日,交易品种以低点1.04和高点1.22进行交易。
关注Fate Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FATE新闻
- Fate Therapeutics reports positive lupus treatment data at ASH meeting
- Fate TherapeuticsQ3每股收益及营收超出预期
- Fate Therapeutics earnings beat by $0.03, revenue topped estimates
- Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
- Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
- 3 Cancer-Focused Stocks Showing Strong Pipeline Progress
- Incyte (INCY) Tops Q3 Earnings and Revenue Estimates
- Fate Therapeutics at Cantor Global Healthcare Conference: CAR T Cell Advances
- Leerink Partners lowers Fate Therapeutics stock price target to $7 on iPSC CAR’iT pivot
- Fate Therapeutics: Recent Update Met With Selling, But Positives Exist
- Wells Fargo lowers Fate Therapeutics stock price target to $2.50 on cost cuts
- Fate Therapeutics earnings beat by $0.05, revenue topped estimates
- Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates
- Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
- Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
- Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates
- H.C. Wainwright maintains Neutral rating on Fate Therapeutics stock at $5
- Needham maintains hold on Fate Therapeutics stock despite lupus data
- Fate Therapeutics price target lowered to $2.20 by BofA on SLE data
- Fate’s FT819 shows promising results in lupus patients
- Guggenheim maintains buy rating on Neurocrine Bio stock amid growth prospects
- RBC Capital maintains outperform rating for Neurocrine Bio stock
- Fate Therapeutics soars 84% following InvestingPro’s April Fair Value alert
- Fate Therapeutics to present lupus treatment data at EULAR 2025
常见问题解答
FATE股票今天的价格是多少?
Fate Therapeutics Inc股票今天的定价为1.19。它在1.04 - 1.22范围内交易,昨天的收盘价为1.05,交易量达到3599。FATE的实时价格图表显示了这些更新。
Fate Therapeutics Inc股票是否支付股息?
Fate Therapeutics Inc目前的价值为1.19。股息政策取决于公司,而投资者也会关注-5.56%和USD。实时查看图表以跟踪FATE走势。
如何购买FATE股票?
您可以以1.19的当前价格购买Fate Therapeutics Inc股票。订单通常设置在1.19或1.49附近,而3599和14.42%显示市场活动。立即关注FATE的实时图表更新。
如何投资FATE股票?
投资Fate Therapeutics Inc需要考虑年度范围0.66 - 1.94和当前价格1.19。许多人在以1.19或1.49下订单之前,会比较19.00%和。实时查看FATE价格图表,了解每日变化。
Fate Therapeutics Inc股票的最高价格是多少?
在过去一年中,Fate Therapeutics Inc的最高价格是1.94。在0.66 - 1.94内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Fate Therapeutics Inc的绩效。
Fate Therapeutics Inc股票的最低价格是多少?
Fate Therapeutics Inc(FATE)的最低价格为0.66。将其与当前的1.19和0.66 - 1.94进行比较,可以发现潜在的长期切入点。观看FATE在图表上的实时走势以获取更多详细信息。
FATE股票是什么时候拆分的?
Fate Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、1.05和-5.56%中可见。
- 前一天收盘价
- 1.05
- 开盘价
- 1.04
- 卖价
- 1.19
- 买价
- 1.49
- 最低价
- 1.04
- 最高价
- 1.22
- 交易量
- 3.599 K
- 日变化
- 13.33%
- 月变化
- 19.00%
- 6个月变化
- 8.18%
- 年变化
- -5.56%
- 实际值
- 预测值
- 前值